SHZ Equity Snapshot
300683 Weekly Equity Report
Wuhan Hiteck Biological Pharma Co.,Ltd
What the company does
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Epramine for injection; mouse nerve growth factor for injection; Anewway, a mouse nerve growth factor for injection; omeprazole sodium for injection, an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome; adenosine cyclophosphate for injection that is used for angina pectoris, myocardial infarction, myocarditis, and cardiogenic shock; aciclovir dispersible tablets for the treatment of genital herpes virus infection, herpes zoster, and immune …
What the weekly tape is saying
300683 closed the latest completed week at 24.97 CNY. The 4-week return is -28.8% and the 12-week return is -23.7%. Trend Signal is inactive, Market Dynamics is -1.04. Setup signature: Risk-first tape with a 7/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 32.03 CNY
- Vs Trend Line
- -22.0%
- Fair Value
- 30.34 CNY
- Vs Fair Value
- -17.7%
- 52W High
- 61.76 CNY
- 52W Low
- 23.80 CNY
- Drawdown
- -59.6%
- Range Position
- 3.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- CN Healthcare
- Sector Rank
- 340 of 486
- Sector Percentile
- 30.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CN Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -0.2%
- Avg 4W
- -7.7%
- Trend Breadth
- 15.0%
- Positive MD
- 24.0%
CN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.0%
- Avg 4W
- -9.3%
- Trend Breadth
- 10.0%
- Positive RS
- 8.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.04
- 4W MD Change
- -813.8%
- Relative Strength
- -36.99
- 4W RS Change
- -123.8%
- Expectation
- Undecided
- Probability
- 51.81%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 17.1M
- 13W Average
- 45.1M
- 52W Average
- 39.6M
- Vs 13W
- 0.4x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.8%
- 52W Volatility
- 11.1%
- Upside Weeks
- 22
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 9.9% / -6.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SHZ
- Country
- CN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- CNY
- Market Cap
- 3.4B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 24.97 CNY | -3.5% | 32.03 CNY | 30.34 CNY | -1.04 | -36.99 | 17.1M | Off |
| 5 Jun 2026 | 25.87 CNY | -5.9% | 32.28 CNY | 30.41 CNY | -0.66 | -36.63 | 23.2M | Off |
| 29 May 2026 | 27.50 CNY | -13.3% | 32.57 CNY | 30.47 CNY | -0.33 | -34.16 | 25.9M | Off |
| 22 May 2026 | 31.72 CNY | -9.5% | 32.77 CNY | 30.51 CNY | 0.01 | -24.50 | 28.6M | On |
| 15 May 2026 | 35.06 CNY | -3.7% | 32.93 CNY | 30.53 CNY | 0.15 | -16.53 | 53.2M | On |
| 8 May 2026 | 36.42 CNY | 3.1% | 32.89 CNY | 30.53 CNY | 0.22 | -13.31 | 22.4M | On |
| 1 May 2026 | 35.34 CNY | 7.6% | 32.80 CNY | 30.52 CNY | 0.46 | -13.30 | 43.1M | On |
| 24 Apr 2026 | 32.84 CNY | -4.0% | 32.76 CNY | 30.54 CNY | 0.77 | -18.47 | 37.6M | On |
| 17 Apr 2026 | 34.20 CNY | -5.5% | 32.91 CNY | 30.57 CNY | 1.13 | -14.79 | 52.5M | On |
| 10 Apr 2026 | 36.19 CNY | -17.6% | 33.15 CNY | 30.59 CNY | 1.15 | -6.13 | 65.5M | On |
| 3 Apr 2026 | 43.90 CNY | 13.1% | 33.37 CNY | 30.60 CNY | 1.18 | 22.14 | 127.1M | Off |
| 27 Mar 2026 | 38.81 CNY | 18.6% | 33.53 CNY | 30.55 CNY | 0.91 | 5.62 | 59.6M | Off |
| 20 Mar 2026 | 32.72 CNY | -5.0% | 33.89 CNY | 30.54 CNY | 0.65 | -11.26 | 30.9M | Off |
| 13 Mar 2026 | 34.46 CNY | 6.3% | 34.64 CNY | 30.58 CNY | 0.61 | -9.18 | 62.1M | Off |